Memantine for autism spectrum disorder-Reference-Cited by-同舟云学术

Memantine for autism spectrum disorder

Published:2022-08-25 Issue:8 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Brignell Amanda¹²³⁴,Marraffa Catherine⁴⁵⁶,Williams Katrina¹²⁴⁵,May Tamara¹

Affiliation:

1. Department of Paediatrics; Monash University; Melbourne Australia

2. Developmental Paediatrics; Monash Children's Hospital; Melbourne Australia

3. Department of Speech Pathology; Australian Catholic University; Melbourne Australia

4. Murdoch Children's Research Institute; Melbourne Australia

5. Department of Paediatrics; University of Melbourne; Melbourne Australia

6. Neurodevelopment and Disability; The Royal Children's Hospital; Melbourne Australia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference139 articles.

1. Safety and efficacy of memantine in children with autism: randomized, placebo-controlled study and open-label extension;Aman;Journal of Child and Adolescent Psychopharmacology,2017

2. Study of pharmacokinetics, safety, efficacy, and tolerability of memantine in children with autism clinicaltrials.gov/ct2/show/NCT00872898

3. Efficacy of memantine as adjunct therapy for autism spectrum disorder in children aged <14 years;Karahmadi;Advanced Biomedical Research,2018

4. A multi-site double-blind placebo-controlled trial of memantine versus placebo in children with autism (MEM) clinicaltrials.gov/ct2/show/NCT01372449

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: a unique presentation of memantine overdose causing echolalia and hypertension;BMC Geriatrics;2024-02-01

2. Cannabinoid treatment for the symptoms of autism spectrum disorder;Expert Opinion on Emerging Drugs;2024-01-16

3. Pharmacological treatments in autism spectrum disorder: a narrative review;J PSYCHOPATHOL;2023

4. Editorial: Cannabidiol treatment in neurotherapeutic interventions, volume II;Frontiers in Pharmacology;2023-02-23